文献速递骨软组织肉瘤与黑色素瘤

基于CT的影像组学分类模型预测腹膜后肉瘤组织学类型与肿瘤分级(RADSARC-R):一项回顾性多队列分析

A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis.
PubMed 文献 · Lancet Oncol · 2023-01-01

该回顾性多队列分析在皇家马斯登医院发现队列(170例)和STRASS试验独立验证队列(89例)中开发并验证基于CT的影像组学分类模型,用于预测腹膜后平滑肌肉瘤与脂肪肉瘤的组织学类型及分级。验证队列中组织学类型预测模型AUROC为0.928,分级预测模型AUROC为0.882。作者认为该模型性能优异,可能对改善诊断和风险分层有重要意义。

要点

  • 验证队列中组织学类型预测模型AUROC为0.928,基于影像组学联合近似影像组学体积分数特征集。
  • 验证队列中分级预测模型AUROC为0.882,基于影像组学特征集。
  • 作者认为该验证模型能优异预测腹膜后肉瘤组织学类型和分级。

核心结论

  • 作者认为,经验证的影像组学模型能以优异性能预测腹膜后肉瘤的组织学类型和分级,可能对改善腹膜后肉瘤的诊断和风险分层有重要意义。

研究设计与样本

  • 回顾性发现队列在本中心(英国伦敦皇家马斯登医院)收集,独立验证队列由STRASS三期新辅助放疗研究入组的患者组成。
  • 纳入年龄大于18岁、确诊原发性平滑肌肉瘤或脂肪肉瘤、接受手术切除且有可用增强CT扫描的患者。
  • 使用发现数据集开发基于CT的影像组学工作流程,包括手动勾画、子分割、特征提取和预测模型构建。
  • 分别构建并测试用于预测组织学类型以及低级别与中或高级别肿瘤的概率分类器,随后进行独立验证。
  • 发现队列170例于2016年10月30日至2020年12月23日入组,验证队列89例于2012年1月18日至2017年4月10日入组。

主要发现

  • 发现队列中位年龄63岁(范围27-89),女性83例(49%),男性87例(51%)。
  • 验证队列中位年龄59岁(范围33-77),女性46例(52%),男性43例(48%)。
  • 验证队列中组织学类型预测性能最高的模型AUROC为0.928,基于影像组学联合近似影像组学体积分数特征集。
  • 验证队列中分级预测性能最高的模型AUROC为0.882,基于影像组学特征集。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Retroperitoneal sarcomas are tumours with a poor prognosis. Upfront characterisation of the tumour is difficult, and under-grading is common. Radiomics has the potential to non-invasively characterise the so-called radiological phenotype of tumours. We aimed to develop and independently validate a CT-based radiomics classification model for the prediction of histological type and grade in retroperitoneal leiomyosarcoma and liposarcoma. METHODS: A retrospective discovery cohort was collated at our centre (Royal Marsden Hospital, London, UK) and an independent validation cohort comprising patients recruited in the phase 3 STRASS study of neoadjuvant radiotherapy in retroperitoneal sarcoma. Patients aged older than 18 years with confirmed primary leiomyosarcoma or liposarcoma proceeding to surgical resection with available contrast-enhanced CT scans were included. Using the discovery dataset, a CT-based radiomics workflow was developed, including manual delineation, sub-segmentation, feature extraction, and predictive model building. Separate probabilistic classifiers for the prediction of histological type and low versus intermediate or high grade tumour types were built and tested. Independent validation was then performed. The primary objective of the study was to develop radiomic classification models for the prediction of retroperitoneal leiomyosarcoma and liposarcoma type and histological grade. FINDINGS: 170 patients recruited between Oct 30, 2016, and Dec 23, 2020, were eligible in the discovery cohort and 89 patients recruited between Jan 18, 2012, and April 10, 2017, were eligible in the validation cohort. In the discovery cohort, the median age was 63 years (range 27-89), with 83 (49%) female and 87 (51%) male patients. In the validation cohort, median age was 59 years (range 33-77), with 46 (52%) female and 43 (48%) male patients. The highest performing model for the prediction of histological type had an area under the receiver operator curve (AUROC) of 0·928 on validation, based on a feature set of radiomics and approximate radiomic volume fraction. The highest performing model for the prediction of histological grade had an AUROC of 0·882 on validation, based on a radiomics feature set. INTERPRETATION: Our validated radiomics model can predict the histological type and grade of retroperitoneal sarcomas with excellent performance. This could have important implications for improving diagnosis and risk stratification in retroperitoneal sarcomas. FUNDING: Wellcome Trust, European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group, the National Institutes for Health, and the National Institute for Health and Care Research Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Arthur A, Orton MR, Emsley R, et al. A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis. Lancet Oncol. 2023. PMID: 37922931. doi:10.1016/S1470-2045(23)00462-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。